Chelsea and Westminster NHS Foundation Trust
81
9
10
35
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.2%
5 terminated/withdrawn out of 81 trials
87.5%
+1.0% vs industry average
14%
11 trials in Phase 3/4
20%
7 of 35 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (81)
Echocardiography: Value and Accuracy at REst and STress
Role: collaborator
Early Vasopressors in Sepsis
Role: collaborator
Trans People Living With HIV Throughout Europe
Role: lead
The Effect of Dolutegravir on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers
Role: lead
Endometrioma Sclerotherapy and Ovarian Preservation
Role: lead
Spoken Animation for Labour Epidural
Role: lead
Mifepristone Outpatient Labour Induction
Role: lead
Genetic Determinants of Kidney Disease in People of African Ancestry With HIV
Role: collaborator
Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy
Role: collaborator
Muscle Connective Tissue in Limb Development and Disease
Role: collaborator
Electroacupuncture as a Treatment for Refractory Overactive Bladder
Role: lead
Addressing Pregnant Women's First Trimester Worries and Information Needs With mHealth Solutions
Role: collaborator
COlorectal BReath Analysis (COBRA2)
Role: collaborator
Lower Urinary Tract Symptoms in Transmasculine Patients Undergoing Metoidioplasty and Their Acceptability of Pelvic Floor Muscle Training Assessed by a Pelvic, Obstetric and Gynaecological Physiotherapist
Role: lead
TB PCR in BAL and EBUS-TBNA
Role: collaborator
RASECAL-Bronchoscopic Ambusampler
Role: lead
The Effect on Lipid Profile of Switching to Delstrigo in HIV Positive Patients
Role: lead
The Effect of Biktarvy (B/F/TAF) on Whole-body Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers
Role: lead
Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volunteers
Role: lead
Implementing Long-Acting Novel Antiretrovirals
Role: collaborator